An Open-Label Study of Apabetalone in Covid Infection
Clinical trial NCT04894266 · TERMINATED
Trial details
- NCT number
- NCT04894266
- Sponsor
- Resverlogix Corp
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-14
- Primary completion
- 2022-06-22
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.